H&H国际控股(01112.HK)中期纯利升85.5%至7.13亿元
格隆汇8月20日丨H&H国际控股(01112.HK)公布，截至2019年6月30日止6个月，公司实现收入为人民币50.95亿元(单位下同)，同比增长11.4%；毛利为34.23亿元，同比增长11.3%；EBITDA为12.99亿元，同比增长34.5%；经调整可比EBITDA为11.94亿元，同比减少4.4%；纯利7.13亿元，同比增长85.5%；经调整可比纯利6.09亿元，同比减少13.1%；基本每股盈利1.11元。
凭藉上半年推出的多品牌/类别策略及多项计划以带动消费者对优质婴幼儿营养及护理产品类别的需求，婴幼儿营养及护理用品业务所得收入于今年上半年达32.61亿元，与去年同期相比增加17.4%。该等计划包括以集团专属妈妈100忠诚计划有效地招揽新消费者及留住现有消费者；及加强数字及社交媒体营销及专业人士代言，以提高品牌知名度及口碑效应。
由于去年中国出生率不断下降，婴幼儿配方奶粉在中国市场维持激烈竞争，今年初以来市场增长开始放缓。虽然高端及超高端分部增长依然强劲，婴幼儿配方奶粉行业截至2019年6月30日止十二个月录得较低增长率，为11.6%。尽管走势如此，相比去年同期，集团的婴幼儿配方奶粉分部增速胜过市场增速，销售增长14.7%，并继续于高端及超高端分部占有重要地位。集团的Healthy Times婴幼儿配方奶粉系列表现胜过整体有机婴幼儿配方奶粉市场，销售增长为42.7%，占其整体婴幼儿配方奶粉业务的5.1%。根据独立市场研究公司尼尔森(Nielsen)的资料，集团所占中国整体婴幼儿配方奶粉市场的份额于截至2019年6月30日止十二个月保持稳定，为5.9%。
集团亦扩大于澳洲、中国香港及法国等其他市场的据点，包括于2019年初在澳洲及新西兰市场推出Biostime有机婴幼儿配方奶粉产品及益生菌产品，并委任知名超模及两子的母Miranda Kerr担任Biostime的品牌大使。同时，集团透过跨境电子商务平台及中国香港市场推出Biostime品牌旗下的婴幼儿配方羊奶粉系列，成功扩展了婴幼儿配方奶粉产品系列，从而进军中国发展迅速的羊奶粉市场。法国作为欧洲最大的有机婴儿食品市场，其有机婴幼儿配方奶粉市场近年来的销售增长势不可挡。根据独立研究数据供应商GERS的资料，Biostime已随着此增长趋势，于药房渠道的有机婴幼儿配方奶粉品牌中排名第二，显示增长非常稳健，亦广受法国母亲们认可。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
